Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible.Our proprietary approach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 29, 2021 | Series C | $276M | 10 | Venrock | — | Detail |
Jun 26, 2020 | Series B | $30M | 2 | — | — | Detail |
Jan 9, 2020 | Series B | $80M | 4 | — | — | Detail |
Jun 18, 2019 | Series A | $15M | 2 | Foresite Capital Venrock | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Venrock | Yes | Series C |
Counterpoint Global | — | Series C |
Fidelity Management and Research Company | — | Series C |
Foresite Capital | — | Series C |
Janus Henderson Investors | — | Series C |
JS Capital Management | — | Series C |
Logos Capital | — | Series C |
Meritech Capital Partners | — | Series C |
RA Capital Management | — | Series C |
T. Rowe Price | — | Series C |
Element Biosciences has acquired 1 organizations. Their most recent acquisition was Loop Genomics on Feb 8, 2022. They acquired Loop Genomics for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Feb 8, 2022
Loop Genomics
|
Biotechnology | acquisition | — | Detail |